rti 121 has been researched along with benserazide in 1 studies
| Studies (rti 121) | Trials (rti 121) | Recent Studies (post-2010) (rti 121) | Studies (benserazide) | Trials (benserazide) | Recent Studies (post-2010) (benserazide) |
|---|---|---|---|---|---|
| 64 | 1 | 11 | 1,113 | 162 | 156 |
| Protein | Taxonomy | rti 121 (IC50) | benserazide (IC50) |
|---|---|---|---|
| Genome polyprotein | Coxsackievirus B3 (strain Nancy) | 2.4 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.14 | |
| Hexokinase-2 | Homo sapiens (human) | 5.52 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bordia, T; Drenan, RM; McGregor, M; McIntosh, JM; Quik, M | 1 |
1 other study(ies) available for rti 121 and benserazide
| Article | Year |
|---|---|
Evidence for a role for α6(∗) nAChRs in l-dopa-induced dyskinesias using Parkinsonian α6(∗) nAChR gain-of-function mice.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Antiparkinson Agents; Benserazide; Cocaine; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Levodopa; Male; Mice; Mice, Transgenic; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinsonian Disorders; Protein Binding; Receptors, Nicotinic | 2015 |